Chugai Pharmaceutical Co., Ltd. (CHGCY)

Chugai Pharmaceutical Co. Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	325,472	374,429	302,995	214,733	157,560
Depreciation & Amortization	31,740	31,434	30,868	30,476	26,401
Other Operating Activities	54,114	-161,751	-54,237	-40,174	22,680
Operating Cash Flow	411,326	244,112	279,626	205,035	206,641
Operating Cash Flow Growth	68.50%	-12.70%	36.38%	-0.78%	73.54%
Capital Expenditures	-74,258	-71,239	-72,866	-61,411	-61,177
Acquisitions	19,346	1,048	6,897	4,349	8,168
Change in Investments	-1,092,945	-961,921	-697,292	-459,639	-494,682
Other Investing Activities	1,109,085	886,118	644,334	418,389	465,950
Investing Cash Flow	-38,772	-145,994	-118,927	-98,312	-81,741
Dividends Paid	-131,594	-138,220	-98,644	-91,442	0
Common Stock Issued	217	241	322	440	735
Share Repurchases	-5	-5	-8	-30	-25
Other Financing Activities	-7,878	-7,667	-9,094	-8,525	-67,632
Financing Cash Flow	-139,250	-145,641	-107,408	-99,497	-66,872
Net Cash Flow	236,505	-45,584	55,420	8,392	57,081
Free Cash Flow	337,068	172,873	206,760	143,624	145,464
Free Cash Flow Growth	94.98%	-16.39%	43.96%	-1.26%	251.34%
Free Cash Flow Margin	30.33%	13.72%	20.68%	18.25%	21.20%
Free Cash Flow Per Share	204.84	105.07	125.67	87.31	88.45

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.